MERS: Global Health Threat With High Mortality Rate
Middle East Respiratory Syndrome (MERS), a severe respiratory disease caused by a coronavirus, has been diagnosed in 25 countries since its discovery in Saudi Arabia in 2012. Only two cases have been confirmed in the United States, both in 2014.
MERS is primarily a zoonotic virus, capable of transmission between humans and animals, with camels being a significant source of infection. Symptoms typically appear 5 to 6 days after exposure, but can take anywhere from 2 to 14 days. These symptoms often mimic the flu, but in severe cases, can lead to organ damage and even death. The World Health Organization (WHO) reports a high mortality rate, with approximately 35% of diagnosed cases resulting in fatality.
The majority of MERS cases have been identified in the Middle East, Africa, and South Asia, with the Arabian Peninsula serving as the origin region. The initial known cases were concentrated mainly in Saudi Arabia.
MERS is a serious health concern, with a high mortality rate and the potential for global spread. Further research and vigilance are crucial to prevent and manage outbreaks. As of now, only two cases have been confirmed in the United States, both in 2014.
Read also:
- Rise in Flu Cases: Timing and Reasons Explored by Medical Experts for Flu Vaccination
- Nursing Infants: Advantages, Factors to Ponder, Guidelines, Essential Gear
- Anticipated Increase in Uninsured Residents to Pose Challenge for Local Healthcare Infrastructure
- Accusations of poor care and supposedly poor hygienic standards at LaSalle Hospital
